
Sign up to save your podcasts
Or


Can Text Messages Really Improve Endocrine Therapy Adherence?
Dr Anna Singleton is a Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her research focuses on co-designing and implementing accessible and scalable digital health services to improve health outcomes for people living with and beyond cancer.
We spoke with her about the EMPOWER-SMS clinical trial and what it aims to achieve for breast cancer patients.
Like this episode? Follow Breast Cancer Trials on Social Media:
Guest: Dr Anna Singleton
Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.
Find out more: www.breastcancertrials.org.au
By Breast Cancer TrialsCan Text Messages Really Improve Endocrine Therapy Adherence?
Dr Anna Singleton is a Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her research focuses on co-designing and implementing accessible and scalable digital health services to improve health outcomes for people living with and beyond cancer.
We spoke with her about the EMPOWER-SMS clinical trial and what it aims to achieve for breast cancer patients.
Like this episode? Follow Breast Cancer Trials on Social Media:
Guest: Dr Anna Singleton
Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.
Find out more: www.breastcancertrials.org.au